C-reactive protein as a potential predictive biomarker for kidney cancer
A recent study published in Science Direct describes how a [...]
A recent study published in Science Direct describes how a [...]
Immune checkpoint inhibitors (ICIs), such as nivolumab and ipilimumab have [...]
In this interview with OncLive, professor Sumanta Kumar Pal from [...]
The combination of nivolumab with ipilimumab has been proven to [...]
In this interview taken from the International Kidney Cancer Symposium [...]
A recent phase II clinical trial has shown that combined [...]
Currently, doctors are unsure which is the best first-line treatment [...]
In this paper, three clinical trials with immunotherapy combinations for [...]
A recent phase 1b clinical trial investigated the use of [...]
Results from the ADAPTeR study to evaluate the role of [...]